149 related articles for article (PubMed ID: 16240900)
1. Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis.
Mucsi I; Almási C; Deák G; Marton A; Ambrus C; Berta K; Lakatos P; Szabó A; Horváth C
Clin Nephrol; 2005 Oct; 64(4):288-94. PubMed ID: 16240900
[TBL] [Abstract][Full Text] [Related]
2. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
3. No Associations of 25-Hydroxycholecalciferol and Parathyroid Hormone Concentrations with Calcaneal Bone Characteristics in Community-Dwelling Elderly Subjects: A Cross-Sectional Study.
Jungert A; Neuhäuser-Berthold M
J Nutr Health Aging; 2017; 21(6):733-742. PubMed ID: 28537341
[TBL] [Abstract][Full Text] [Related]
4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
5. Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4.
Stavroulopoulos A; Porter CJ; Roe SD; Hosking DJ; Cassidy MJ
Nephrology (Carlton); 2008 Feb; 13(1):63-7. PubMed ID: 18199106
[TBL] [Abstract][Full Text] [Related]
6. Loss of bone mineral density in renal transplantation recipients.
Unal A; Kocyigit I; Sipahioglu MH; Tokgoz B; Kavuncuoglu F; Oymak O; Utas C
Transplant Proc; 2010 Nov; 42(9):3550-3. PubMed ID: 21094813
[TBL] [Abstract][Full Text] [Related]
7. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
Aggarwal A; Yadav AK; Ramachandran R; Kumar V; Kumar V; Sachdeva N; Khandelwal N; Jha V
Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
[TBL] [Abstract][Full Text] [Related]
8. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients.
Jeong JU; Lee HK; Kim YJ; Kim JS; Kang SS; Kim SB
Clin Nephrol; 2010 Nov; 74(5):336-42. PubMed ID: 20979940
[TBL] [Abstract][Full Text] [Related]
9. Assessment of immune status in relation to vitamin D levels in children on regular hemodialysis.
Youssef DM; Elshal AS; Abo Elazem AA
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):267-73. PubMed ID: 22382217
[TBL] [Abstract][Full Text] [Related]
10. Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.
Jungert A; Neuhäuser-Berthold M
Nutr Res; 2013 Aug; 33(8):661-7. PubMed ID: 23890356
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotegerin and bone mineral density in hemodiafiltration patients.
Crisafulli A; Romeo A; Floccari F; Aloisi E; Atteritano M; Cincotta M; Aloisi C; Pizzoleo MA; Ruello A; Artemisia A; Valenti A; Frisina N; Teti D; Buemi M
Ren Fail; 2005; 27(5):531-9. PubMed ID: 16152990
[TBL] [Abstract][Full Text] [Related]
12. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.
Kirkpantur A; Altun B; Hazirolan T; Akata D; Arici M; Kirazli S; Turgan C
Artif Organs; 2009 Oct; 33(10):844-54. PubMed ID: 19681840
[TBL] [Abstract][Full Text] [Related]
13. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
Ooms ME; Lips P; Roos JC; van der Vijgh WJ; Popp-Snijders C; Bezemer PD; Bouter LM
J Bone Miner Res; 1995 Aug; 10(8):1177-84. PubMed ID: 8585420
[TBL] [Abstract][Full Text] [Related]
15. The influence of serum 25-hydroxy vitamin D levels on Helicobacter Pylori Infections in patients with end-stage renal failure on regular hemodialysis.
Nasri H; Baradaran A
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):215-9. PubMed ID: 17496397
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study.
von Mühlen DG; Greendale GA; Garland CF; Wan L; Barrett-Connor E
Osteoporos Int; 2005 Dec; 16(12):1721-6. PubMed ID: 15928802
[TBL] [Abstract][Full Text] [Related]
19. Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis.
Kiss Z; Ambrus C; Almasi C; Berta K; Deak G; Horonyi P; Kiss I; Lakatos P; Marton A; Molnar MZ; Nemeth Z; Szabo A; Mucsi I
Nephron Clin Pract; 2011; 117(4):c373-8. PubMed ID: 21071961
[TBL] [Abstract][Full Text] [Related]
20. Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis.
Taskapan H; Ersoy FF; Passadakis PS; Tam P; Memmos DE; Katopodis KP; Ozener C; Akcicek F; Camsari T; Ates K; Ataman R; Vlachojannis JG; Dombros NA; Utas C; Akpolat T; Bozfakioglu S; Wu G; Karayaylali I; Arinsoy T; Stathakis CP; Yavuz M; Tsakiris DJ; Dimitriades AD; Yilmaz ME; Gültekin M; Oreopoulos DG
Clin Nephrol; 2006 Oct; 66(4):247-55. PubMed ID: 17063991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
